Related Experiment Video
Updated: Jul 5, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Accidental ingestion of superwarfarins]
M Beriain Rodríguez1, B Gómez Cortés, J Benito Fernández
1Urgencias de Pediatría, Hospital de Cruces, Baracaldo, Vizcaya, España.
Superwarfarins, developed to combat rodent resistance, are now common rodenticide poisons. This study highlights five rare pediatric cases of superwarfarin poisoning, emphasizing the need for awareness in emergency departments.
Area of Science:
- Toxicology
- Pediatric Emergency Medicine
- Public Health
Background:
- Superwarfarins emerged in the 1970s to address rodent resistance to older rodenticides.
- These compounds are now a leading cause of rodenticide-induced poisonings globally.
- Pediatric poisonings involving superwarfarins are historically uncommon in clinical settings.
Observation:
- This report details five cases of unintentional superwarfarin ingestion in children under four years old.
- These children were admitted to a Pediatric Emergency Department within a one-year period.
- The cases prompted a review of existing literature on superwarfarin toxicity in children.
Findings:
- The study identifies a cluster of previously rare pediatric superwarfarin poisonings.
- It underscores the potential for accidental ingestion in young children.
- The findings highlight the need for increased vigilance and diagnostic consideration.
Implications:
- Enhanced awareness among healthcare providers is crucial for timely diagnosis and management of superwarfarin poisoning in children.
- Public health strategies may need to address the accessibility of superwarfarin-based rodenticides to prevent pediatric exposures.
- Further research into the specific risks and clinical manifestations of superwarfarin toxicity in pediatric populations is warranted.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Prevention of Further Absorption of Poison
Pharmaceutical Poisoning: Potential Scenarios
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Vitamins